581 related articles for article (PubMed ID: 19061963)
21. Insulin rescues amyloid beta-induced impairment of hippocampal long-term potentiation.
Lee CC; Kuo YM; Huang CC; Hsu KS
Neurobiol Aging; 2009 Mar; 30(3):377-87. PubMed ID: 17692997
[TBL] [Abstract][Full Text] [Related]
22. [Brain-derived neurotrophic factor prevents against amyloid beta protein-induced impairment of hippocampal in vivo long-term potentiation in rats].
Li QS; Yang W; Pan YF; Min J; Zhang Z; Gao HZ; Qi JS
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Sep; 28(5):425-9. PubMed ID: 23252296
[TBL] [Abstract][Full Text] [Related]
23. GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid.
Gault VA; Hölscher C
Eur J Pharmacol; 2008 Jun; 587(1-3):112-7. PubMed ID: 18466898
[TBL] [Abstract][Full Text] [Related]
24. Agonists of peroxisome proliferator-activated receptor-gamma attenuate the Abeta-mediated impairment of LTP in the hippocampus in vitro.
Costello DA; O'Leary DM; Herron CE
Neuropharmacology; 2005 Sep; 49(3):359-66. PubMed ID: 15993441
[TBL] [Abstract][Full Text] [Related]
25. Repetitive induction of late-phase LTP produces long-lasting synaptic enhancement accompanied by synaptogenesis in cultured hippocampal slices.
Tominaga-Yoshino K; Urakubo T; Okada M; Matsuda H; Ogura A
Hippocampus; 2008; 18(3):281-93. PubMed ID: 18058822
[TBL] [Abstract][Full Text] [Related]
26. Late phase of long-term potentiation induced by co-application of N-methyl-d-aspartic acid and the antagonist of NR2B-containing N-methyl-d-aspartic acid receptors in rat hippocampus.
Oh-Nishi A; Saji M; Satoh SZ; Ogata M; Suzuki N
Neuroscience; 2009 Mar; 159(1):127-35. PubMed ID: 19010396
[TBL] [Abstract][Full Text] [Related]
27. The deficit in long-term potentiation induced by chronic administration of amyloid-beta is attenuated by treatment of rats with a novel phospholipid-based drug formulation, VP025.
Miller AM; Piazza A; Martin DS; Walsh M; Mandel A; Bolton AE; Lynch MA
Exp Gerontol; 2009 Apr; 44(4):300-4. PubMed ID: 19121379
[TBL] [Abstract][Full Text] [Related]
28. Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning.
Holscher C; Gengler S; Gault VA; Harriott P; Mallot HA
Eur J Pharmacol; 2007 Apr; 561(1-3):85-90. PubMed ID: 17320856
[TBL] [Abstract][Full Text] [Related]
29. Modulation of amyloid-beta-induced and age-associated changes in rat hippocampus by eicosapentaenoic acid.
Minogue AM; Lynch AM; Loane DJ; Herron CE; Lynch MA
J Neurochem; 2007 Nov; 103(3):914-26. PubMed ID: 17711425
[TBL] [Abstract][Full Text] [Related]
30. Wnt-5a prevents Aβ-induced deficits in long-term potentiation and spatial memory in rats.
Zhang GL; Zhang J; Li SF; Lei L; Xie HY; Deng F; Feng JC; Qi JS
Physiol Behav; 2015 Oct; 149():95-100. PubMed ID: 26032671
[TBL] [Abstract][Full Text] [Related]
31. Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1.
Cammalleri M; Lütjens R; Berton F; King AR; Simpson C; Francesconi W; Sanna PP
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14368-73. PubMed ID: 14623952
[TBL] [Abstract][Full Text] [Related]
32. Age-related deficits in long-term potentiation are insensitive to hydrogen peroxide: coincidence with enhanced autophosphorylation of Ca2+/calmodulin-dependent protein kinase II.
Watson JB; Khorasani H; Persson A; Huang KP; Huang FL; O'Dell TJ
J Neurosci Res; 2002 Nov; 70(3):298-308. PubMed ID: 12391589
[TBL] [Abstract][Full Text] [Related]
33. Stimulus pattern dependence of the Alzheimer's disease amyloid-beta 42 peptide's inhibition of long term potentiation in mouse hippocampal slices.
Smith JP; Lal V; Bowser D; Cappai R; Masters CL; Ciccotosto GD
Brain Res; 2009 May; 1269():176-84. PubMed ID: 19302985
[TBL] [Abstract][Full Text] [Related]
34. Melatonin protects against amyloid-β-induced impairments of hippocampal LTP and spatial learning in rats.
Liu XJ; Yuan L; Yang D; Han WN; Li QS; Yang W; Liu QS; Qi JS
Synapse; 2013 Sep; 67(9):626-36. PubMed ID: 23620224
[TBL] [Abstract][Full Text] [Related]
35. Cholinergic modulation of hippocampal CA1 basal-dendritic long-term potentiation.
Doralp S; Leung LS
Neurobiol Learn Mem; 2008 Sep; 90(2):382-8. PubMed ID: 18590828
[TBL] [Abstract][Full Text] [Related]
36. CaM kinase II and protein kinase C activations mediate enhancement of long-term potentiation by nefiracetam in the rat hippocampal CA1 region.
Moriguchi S; Shioda N; Han F; Narahashi T; Fukunaga K
J Neurochem; 2008 Aug; 106(3):1092-103. PubMed ID: 18445137
[TBL] [Abstract][Full Text] [Related]
37. Pyruvate prevents the inhibition of the long-term potentiation induced by amyloid-β through protein phosphatase 2A inactivation.
Wang X; Takata T; Bai X; Ou F; Yokono K; Sakurai T
J Alzheimers Dis; 2012; 30(3):665-73. PubMed ID: 22451307
[TBL] [Abstract][Full Text] [Related]
38. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ
Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927
[TBL] [Abstract][Full Text] [Related]
39. Synergistic requirements for the induction of dopaminergic D1/D5-receptor-mediated LTP in hippocampal slices of rat CA1 in vitro.
Navakkode S; Sajikumar S; Frey JU
Neuropharmacology; 2007 Jun; 52(7):1547-54. PubMed ID: 17433377
[TBL] [Abstract][Full Text] [Related]
40. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.
Klyubin I; Walsh DM; Lemere CA; Cullen WK; Shankar GM; Betts V; Spooner ET; Jiang L; Anwyl R; Selkoe DJ; Rowan MJ
Nat Med; 2005 May; 11(5):556-61. PubMed ID: 15834427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
